Cite
PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinoma
MLA
Song, Fei, et al. “PANoptosis-Based Molecular Subtyping and HPAN-Index Predicts Therapeutic Response and Survival in Hepatocellular Carcinoma.” Frontiers in Immunology, vol. 14, June 2023. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1197152.
APA
Song, F., Wang, C.-G., Mao, J.-Z., Wang, T.-L., Liang, X.-L., Hu, C.-W., Zhang, Y., Han, L., & Chen, Z. (2023). PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinoma. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1197152
Chicago
Song, Fei, Cheng-Gui Wang, Jia-Zhen Mao, Tian-Lun Wang, Xiao-Liang Liang, Chen-Wei Hu, Yu Zhang, Lu Han, and Zhong Chen. 2023. “PANoptosis-Based Molecular Subtyping and HPAN-Index Predicts Therapeutic Response and Survival in Hepatocellular Carcinoma.” Frontiers in Immunology 14 (June). doi:10.3389/fimmu.2023.1197152.